West Pharmaceutical Services ROA - Return on Assets 2010-2025 | WST

West Pharmaceutical Services return on assets for the quarter ending March 31, 2025 was 12.95.

  • West Pharmaceutical Services average return on assets for 2024 was 14.23, a 7.05% decline from 2023.
  • West Pharmaceutical Services average return on assets for 2023 was 15.31, a 22.32% decline from 2022.
  • West Pharmaceutical Services average return on assets for 2022 was 19.71, a 1.44% decline from 2021.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

West Pharmaceutical Services ROA - Return on Assets 2010-2025 | WST

  • West Pharmaceutical Services average return on assets for 2024 was 14.23, a 7.05% decline from 2023.
  • West Pharmaceutical Services average return on assets for 2023 was 15.31, a 22.32% decline from 2022.
  • West Pharmaceutical Services average return on assets for 2022 was 19.71, a 1.44% decline from 2021.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$87.4B
Becton Dickinson (BDX)$57.1B
Cardinal Health (CAH)$32.5B
Straumann Holding AG (SAUHY)$18.7B
Labcorp (LH)$18.2B
Cooper (COO)$15.9B
Align Technology (ALGN)$12.5B
Henry Schein (HSIC)$7.9B
Merit Medical Systems (MMSI)$5.4B
Patterson (PDCO)$2.8B
DENTSPLY SIRONA (XRAY)$2.6B
CONMED (CNMD)$1.5B
STAAR Surgical (STAA)$833M
Pro-Dex (PDEX)$198M
Lifevantage (LFVN)$169M